Ketorolac

This classification denotes a cyclooxygenase inhibitor with the molecular formula C15H13NO3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier YZI5105V0L, chemically known as 5-benzoyl-2,3-dihydro-1h-pyrrolizine-1-carboxylic acid but generally known as ketorolac, which bears US NIH Compound Identifier 3826. European Medicines Agency schedules Ketorolac in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08376MIG. The term KETOROLAC is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 38, No. 6, 1984, List 24). World Health Organization schedules ketorolac in its Anatomical Therapeutic Chemical (ATC) Classification. KETOROLAC is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule ketorolac under HS 29339990 and SITC 51577. As of Q4 2014, KETOROLAC remains the US FDA Preferred Term for this commodity. Ketorolac bears US NLM identifiers UMLS ID C0073631 and NCI Concept Code C1219. SMILES: OC(=O)C1CCN2C1CCC2C(=O)C1CCCCC1.